Skip to main content
. 2019 Feb 27;14(2):e0211721. doi: 10.1371/journal.pone.0211721

Fig 2. Cumulative incidence curves.

Fig 2

Bladder cancer Recurrence time, progression to high grade Ta / T1 (NMIBC) time; Muscle invasive (MIBC) progression time.